Related references
Note: Only part of the references are listed.Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions
Vivaswath S. Ayyar et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial
Camilla Hauge et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation
Tine A. Baekdal et al.
DIABETES THERAPY (2021)
Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme
Tina K. Thethi et al.
DIABETES OBESITY & METABOLISM (2020)
Dosing time matters
Marc D. Ruben et al.
SCIENCE (2019)
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
Charlotte Granhall et al.
CLINICAL PHARMACOKINETICS (2018)
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide
Tine A. Baekdal et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Tine A. Baekdal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
Stephen T. Buckley et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)